The silent revolution: RNA interference as basic biology, research tool, and therapeutic

Annual Review of Medicine

Volumn 56, Issue , 2005, Pages 401-423

  Dykxhoorn, Derek M ^a   Lieberman, Judy ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

miRNA; Posttranscriptional gene silencing gene therapy; Small interfering RNA

Indexed keywords

COMPLEMENTARY RNA; MESSENGER RNA; RNA; RNA INDUCED SILENCING COMPLEX; SHORT HAIRPIN RNA; SMALL INTERFERING RNA;

CELL FUNCTION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SILENCING; GENE TARGETING; GENE THERAPY; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVIEW; RNA INTERFERENCE; TREATMENT INDICATION; VIRUS GENOME;

ANIMALS; EVOLUTION; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC TECHNIQUES; HUMANS; INFECTION; NEOPLASMS; NEURODEGENERATIVE DISEASES; RNA INTERFERENCE; RNA, MESSENGER; SEQUENCE HOMOLOGY;

EID: 14544280255     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.56.082103.104606     Document Type: Review

References (115)

1. Fire A, Xu S, Montgomery MK, et al. 1998. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391:806-11
2. Jorgensen R. 1990. Altered gene expression in plants due to trans interactions between homologous genes. Trends Biotechnol. 8:340-44
3. Romano N, Macino G. 1992. Quelling: transient inactivation of gene expression in Neurospora crassa by transformation with homologous sequences. Mol. Microbiol. 6:3343-53
4. Pasquinelli AE, Ruvkun G. 2002. Control of developmental timing by microRNAs and their targets. Annu. Rev. Cell Dev. Biol. 18:495-513
5. Fagard M, Boutet S, Morel JB, et al. 2000. AGO1, QDE-2, and RDE-1 are related proteins required for post-transcriptional gene silencing in plants, quelling in fungi, and RNA interference in animals. Proc. Natl. Acad. Sci. USA 97:11650-54
6. Waterhouse PM, Wang MB, Finnegan EJ. 2001. Role of short RNAs in gene silencing. Trends Plant Sci. 6:297-301
7. Bernstein E, Caudy AA, Hammond SM, et al. 2001. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409:363-66
8. Elbashir SM, Harborth J, Lendeckel W, et al. 2001. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494-98
9. Tuschl T, Zamore PD, Lehmann R, et al. 1999. Targeted mRNA degradation by double-stranded RNA in vitro. Genes Dev. 13:3191-97
10. Zamore PD, Tuschl T, Sharp PA, et al. 2000. RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 101:25-33
11. Hamilton AJ, Baulcombe DC. 1999. A species of small antisense RNA in post-transcriptional gene silencing in plants. Science 286:950-52
12. Hammond SM, Bernstein E, Beach D, et al. 2000. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 404:293-96
13. Elbashir SM, Martinez J, Patkaniowska A, et al. 2001. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J. 20:6877-88
14. Dykxhoorn DM, Novina CD, Sharp PA. 2003. Killing the messenger: short RNAs that silence gene expression. Nat. Rev. Mol. Cell Biol. 4:457-67
15. Liu Q, Rand TA, Kalidas S, et al. 2003. R2D2, a bridge between the initiation and effector steps of the Drosophila RNAi pathway. Science 301:1921-25
16. Pham JW, Pellino JL, Lee YS, et al. 2004. A Dicer-2-dependent 80s complex cleaves targeted mRNAs during RNAi in Drosophila. Cell 117:83-94
17. Tomari Y, Du T, Haley B, et al. 2004. RISC assembly defects in the Drosophila RNAi mutant armitage. Cell 116:831-41
18. Hammond SM, Boettcher S, Caudy AA, et al. 2001. Argonaute2, a link between genetic and biochemical analyses of RNAi. Science 293:1146-50
19. Caudy AA, Ketting RF, Hammond SM, et al. 2003. A micrococcal nuclease homologue in RNAi effector complexes. Nature 425:411-14
20. Caudy AA, Myers M, Hannon GJ, et al. 2002. Fragile X-related protein and VIG associate with the RNA interference machinery. Genes. Dev. 16:2491-96
21. Liu J, Carmell MA, Rivas FV, et al. 2004. Argonaute2 is the catalytic engine of mammalian RNAi. Science 305:1437-41
22. Song JJ, Smith SK, Hannon GJ, et al. 2004. Crystal structure of Argonaute and its implications for RISC Slicer activity. Science 305:1434-37
23. Kennedy S, Wang D, Ruvkun G. 2004. A conserved siRNA-degrading RNase negatively r egulates RNA interference in C. elegans. Nature 427:645-49
24. Lim LP, Glasner ME, Yekta S, et al. 2003. Vertebrate microRNA genes. Science 299:1540
25. Aravin AA, Lagos-Quintana M, Yalcin A, et al. 2003. The small RNA profile during Drosophila melanogaster development. Dev. Cell 5:337-50
26. Lee Y, Jeon K, Lee JT, et al. 2002. MicroRNA maturation: stepwise processing and subcellular localization. EMBO. J. 21:4663-70
27. Lee Y, Ahn C, Han J, et al. 2003. The nuclear RNase III Drosha initiates microRNA processing. Nature 425:415-19
28. Houbaviy HB, Murray MF, Sharp PA. 2003. Embryonic stem cell-specific microRNAs. Dev. Cell 5:351-58
29. Doench JG, Petersen CP, Sharp PA. 2003. siRNAs can function as miRNAs. Genes Dev. 17:438-42
30. Saxena S, Jonsson ZO, Dutta A. 2003. Small RNAs with imperfect match to endogenous mRNA repress translation. Implications for off-target activity of small inhibitory RNA in mammalian cells. J. Biol. Chem. 278:44312-19
31. Lagos-Quintana M, Rauhut R, Meyer J, et al. 2003. New microRNAs from mouse and human. RNA 9:175-79
32. Djikeng A, Shi H, Tschudi C, et al. 2001. RNA interference in Trypanosoma brucei: cloning of small interfering RNAs provides evidence for retroposori-derived 24-26-nucleotide RNAs. RNA 7:1522-30
33. Reinhart BJ, Bartel DP. 2002. Small RNAs correspond to centromere heterochromatic repeats. Science 297:1831
34. Zilberman D, Cao X, Jacobsen SE. 2003. ARGONAUTE4 control of locus-specific siRNA accumulation and DNA and histone methylation. Science 299:716-19
35. Tabara H, Sarkissian M, Kelly WG, et al. 1999. The rde-1 gene, RNA interference, and transposon silencing in C. elegans. Cell 99:123-32
36. Schramke V, Allshire R. 2003. Hairpin RNAs and retrotransposon LTRs effect RNAi and chromatin-based gene silencing. Science 301:1069-74
37. Chan SW, Zilberman D, Xie Z, et al. 2004. RNA silencing genes control de novo DNA methylation. Science 303:1336
38. Volpe T, Schramke V, Hamilton GL, et al. 2003. RNA interference is required for normal centromere function in fission yeast. Chromosome Res. 11:137-46
39. Pal-Bhadra M, Leibovitch BA, Gandhi SG, et al. 2004. Heterochromatic silencing and HP1 localization in Drosophila are dependent on the RNAi machinery. Science 303:669-72
40. Verdel A, Jia S, Gerber S, et al. 2004. RNAi-mediated targeting of heterochromatin by the RITS complex. Science 303:672-76
41. Fukagawa T, Nogami M, Yoshikawa M, et al. 2004. Dicer is essential for formation of the heterochromatin structure in vertebrate cells. Nat. Cell Biol. 6:78491
42. a. Morris KV, Chan SW-L, Jacobsen SE, Looney DJ. 2004. Small interfering RNA-induced transcriptional gene silencing in human cells. Science 305:1289-92
43. Brummelkamp TR, Bernards R, Agami R. 2002. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2:243-47
44. Ding H, Schwarz DS, Keene A, et al. 2003. Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis. Aging Cell 2:209-17
45. Miller VM, Gouvion CM, Davidson BL, et al. 2004. Targeting Alzheimer's disease genes with RNA interference: an efficient strategy for silencing mutant alleles. Nucleic Acids Res. 32:661-68
46. Gitlin L, Karelsky S, Andino R. 2002. Short interfering RNA confers intracellular antiviral immunity in human cells. Nature 418:430-34
47. Das AT, Brummelkamp TR, Westerhout EM, et al. 2004. Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J. Virol. 78:2601-5
48. Boden D, Pusch O, Lee F, et al. 2003. Human immunodeficiency virus type 1 escape from RNA interference. J. Virol. 77:11531-35
49. Jacque JM, Triques K, Stevenson M. 2002. Modulation of HIV-1 replication by RNA interference. Nature 418:435-38
50. Czauderna F, Fechtner M, Dames S, et al. 2003. Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells. Nucleic Acids Res. 31:2705-16
51. Amarzguioui M, Holen T, Babaie E, et al. 2003. Tolerance for mutations and chemical modifications in a siRNA. Nucleic Acids Res. 31:589-95
52. Elbashir SM, Lendeckel W, Tuschl T. 2001. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 15:188-200
53. Khvorova A, Reynolds A, Jayasena SD. 2003. Functional siRNAs and miRNAs exhibit strand bias. Cell 115:209-16
54. Schwarz DS, Hutvagner G, Du T, et al. 2003. Asymmetry in the assembly of the RNAi enzyme complex. Cell 115:199-208
55. Jackson AL, Bartz SR, Schelter J, et al. 2003. Expression profiling reveals off-target gene regulation by RNAi. Nat. Biotechnol. 21:635-37
56. Stark GR, Kerr IM, Williams BR, et al. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67:227-64
57. Persengiev SP, Zhu X, Green MR. 2004. Nonspecific, concentration- dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). RNA 10:12-18
58. Sledz CA, Holko M, de Veer MJ, et al. 2003. Activation of the Interferon system by short-interfering RNAs. Nat. Cell Biol. 5:834-39
59. Bridge AJ, Pebernard S, Ducraux A, et al. 2003. Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet. 34:263-64
60. Zeng Y, Wagner EJ, Cullen BR. 2002. Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Mol. Cell 9:1327-33
61. Waterhouse PM, Wang MB, Lough T. 2001. Gene silencing as an adaptive defence against viruses. Nature 411:834-42
62. Ye K, Malinina L, Patel DJ. 2003. Recognition of small interfering RNA by a viral suppressor of RNA silencing. Nature 426:874-78
63. Wang MB, Bian XY, Wu LM, et al. 2004. On the role of RNA silencing in the pathogenicity and evolution of viroids and viral satellites. Proc. Natl. Acad. Sci. USA 101:3275-80
64. Pfeffer S, Zavolan M, Grasser FA, et al. 2004. Identification of virus-encoded microRNAs. Science 304:734-36
65. Li WX, Li H, Lu R, et al. 2004. Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing. Proc. Natl. Acad. Sci. USA 101:1350-55
66. Bartel DP. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-97
67. Lewis BP, Shih IH, Jones-Rhoades MW, et al. 2003. Prediction of mammalian microRNA targets. Cell 115:787-98
68. Wightman B, Ha I, Ruvkun G. 1993. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75:855-62
69. Lee RC, Feinbaum RL, Ambros V. 1993. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843-54
70. Chen CZ, Li L, Lodish HF, et al. 2004. MicroRNAs modulate hematopoietic lineage differentiation. Science 303:83-86
71. Song E, Lee SK, Dykxhoorn DM, et al. 2003. Sustained small interfering RNA-mediated human immunodeficiency virus type 1 inhibition in primary macrophages. J. Virol. 77:7174-81
72. Song E, Lee SK, Wang J, et al. 2003. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat. Med. 9:347-51
73. Omi K, Tokunaga K, Hohjoh H. 2004. Long-lasting RNAi activity in mammalian neurons. FEBS Lett. 558:89-95
74. Dorsett Y, Tuschl T. 2004. siRNAs: applications in functional genomics and potential as therapeutics. Nat. Rev. Drug. Discov. 3:318-29
75. Fraser AG, Kamath RS, Zipperlen P, et al. 2000. Functional genomic analysis of C. elegans chromosome I by systematic RNA interference. Nature. 408:325-30
76. Boutros M, Kiger AA, Armknecht S, et al. 2004. Genome-wide RNAi analysis of growth and viability in Drosophila cells. Science 303:832-35
77. Paddison PJ, Silva JM, Conklin DS, et al. 2004. A resource for large-scale RNA-interference-based screens in mammals. Nature 428:427-31
78. Berns K, Hijmans EM, Mullenders J, et al. 2004. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 428:431-37
79. Timmons L, Fire A. 1998. Specific interference by ingested dsRNA. Nature 395:854
80. Lois C, Hong EJ, Pease S, et al. 2002. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295:868-72
81. Rubinson DA, Dillon CP, Kwiatkowski AV, et al. 2003. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 33:401-6
82. Hasuwa H, Kaseda K, Einarsdottir T, et al. 2002. Small interfering RNA and gene silencing in transgenic mice and rats. FEBS Lett. 532:227-30
83. Wiznerowicz M, Trono D. 2003. Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J. Virol. 77:8957-61
84. Hommel JD, Sears RM, Georgescu D, et al. 2003. Local gene knockdown in the brain using viral-mediated RNA interference. Nat. Med. 9:1539-44
85. Gupta S, Schoer RA, Egan JE, et al. 2004. Inducible, reversible, and stable RNA interference in mammalian cells. Proc. Natl. Acad. Sci. USA 101:1927-32
86. Hemann MT, Fridman JS, Zilfou JT, et al. 2003. An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo. Nat. Genet. 33:396-400
87. Bertrand JR, Pottier M, Vekris A, et al. 2002. Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo. Biochem. Biophys. Res. Commun. 296:1000-4
88. Scacheri PC, Rozenblatt-Rosen O, Caplen NJ, et al. 2004. Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. Proc. Natl. Acad. Sci. USA 101:1892-97
89. Pebernard S, Iggo RD. 2004. Determinants of interferon-stimulated gene induction by RNAi vectors. Differentiation 72:103-11
90. Kariko K, Bhuyan P, Capodici J, et al. 2004. Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through Toll-like receptor 3. J. Immunol. 172:6545-49
91. Lieberman J, Song E, Lee SK, et al. 2003. Interfering with disease: opportunities and roadblocks to harnessing RNA interference. Trends Mol. Med. 9:397-403
92. Davidson BL, Paulson HL. 2004. Molecular medicine for the brain: silencing of disease genes with RNA interference. Lancet Neurol. 3:145-49
93. Xia H, Mao Q, Paulson HL, et al. 2002. siRNA-mediated gene silencing in vitro and in vivo. Nat. Biotechnol. 20:1006-10
94. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al. 2003. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302:415-19
95. Stewart SA, Dykxhoorn DM, Palliser D, et al. 2003. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 9:493-501
96. Simeoni F, Morris MC, Heitz F, et al. 2003. Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells. Nucleic Acids Res. 31:2717-24
97. Ge Q, Filip L, Bai A, et al. 2004. Inhibition of influenza virus production in virus-infected mice by RNA interference. Proc. Natl. Acad. Sci. USA 101:8676-81
98. Chiu YL, Rana TM. 2003. siRNA function in RNAi: a chemical modification analysis. RNA 9:1034-48
99. Layzer JM, McCaffrey AP, Tanner AK, et al. 2004. In vivo activity of nuclease-resistant siRNAs. RNA 10:766-71
100. McCaffrey AP, Meuse L, Pham TT, et al. 2002. RNA interference in adult mice. Nature 418:38-39
101. Lewis DL, Hagstrom JE, Loomis AG, et al. 2002. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat. Genet. 32:107-8
102. Zhang Y, Zhang YF, Bryant J, et al. 2004. Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer. Clin. Cancer Res. 10:3667-77
103. Giladi H, Ketzinel-Gilad M, Rivkin L, et al. 2003. Small interfering RNA inhibits hepatitis B virus replication in mice. Mol. Ther. 8:769-76
104. McCaffrey AP, Nakai H, Pandey K, et al. 2003. Inhibition of hepatitis B virus in mice by RNA interference. Nat. Biotechnol. 21:639-44
105. Dorn G, Patel S, Wotherspoon G, et al. 2004. siRNA relieves chronic neuropathic pain. Nucleic Acids Res. 32:e49
106. Hamar P, Song E, Kokeny G, et al. 2004. Small interfering RNA targeting fas protects mice against renal ischemia-reperfusion injury. Proc. Natl. Acad. Sci. USA in press
107. Sorensen DR, Leirdal M, Sioud M. 2003. Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J. Mol. Biol 327:761-66
108. Matsuda T, Cepko CL. 2004. Electroporation and RNA interference in the rodent retina in vivo and in vitro. Proc. Natl. Acad. Sci. USA 101:16-22
109. Takei Y, Kadomatsu K, Yuzawa Y, et al. 2004. A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics. Cancer Res. 64:3365-70
110. Mohmmed A, Dasaradhi PV, Bhatnagar RK, et al. 2003. In vivo gene silencing in Plasmodium berghei-a mouse malaria model. Biochem. Biophys. Res. Commun. 309:506-11
111. Narasimhan S, Montgomery RR, DePonte K, et al. 2004. Disruption of Ixodes scapularis anticoagulation by using RNA interference. Proc. Natl. Acad. Sci. USA 101:1141-46
112. Van den Haute C, Eggermont K, Nuttin B, et al. 2003. Lentiviral vector-mediated delivery of short hairpin RNA results in persistent knockdown of gene expression in mouse brain. Hum. Gene. Ther. 14:1799-807
113. Xia H, Mao Q, Eliason SL, et al. 2004. RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nat. Med. 10:816-20
114. + progenitor cell-derived macrophages. Mol. Ther. 8:62-71
115. Yi R, Qin Y, Macara IG, et al. 2003. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 17:3011-16